Family Medicine Initiative

APRIL 9, 2024

So, which patients should get them first? Patients ask me these questions fairly often, so I know it’s important for GPs to know the key facts. Yes, one year after stopping the medication, patients regain ½ – ⅔ of their previous weight loss: What are other clinical benefits? mg or placebo in 2019.

Diabetes 130

Diabetes Patients Medical Family Medicine 130

Physician's Weekly

JUNE 22, 2025

Semaglutide therapy in patients with obese heart failure leads to marked weight loss and notable gains in mood, function, and QoL over the course of 1 year.

Individual 52

Individual Diabetes Hospital Clinic 52

Medical Xpress

JUNE 8, 2025

Long-term effects of pain in early life We collected data on the number of procedures, clinical exposures and sucrose doses from three NICUs across Canada. But as the findings from our Canadian study show, we urgently need research to improve long-term health outcomes for children born prematurely.

IT 53

IT Management Vaccination Medical 53

FDA Law Blog

SEPTEMBER 13, 2021

A May 2019 CMS final rule that would have required drug TV advertisements to disclose the WAC of the drug was challenged by a group of pharmaceutical companies and vacated on statutory grounds by the D.C. Controlling Medicare Part D Patient Out-of-Pocket Costs and Total Drug Costs.

Manufacturing 98

Manufacturing Supply Chain Patient-Centered Utilities 98